Cerevel Therapeutics Holdings Inc. (CERE) NASDAQ
$42.12 (0.02) (-0.05%)
Market Cap: $7.65B
As of 04/19/24 03:42 PM EDT. Market open.
Cerevel Therapeutics Holdings Inc. (CERE)
NASDAQ
$42.12
(0.02) (-0.05%)
Market Cap: $7.65B
As of 04/19/24 03:42 PM EDT. Market open.
Add to Portfolio
cerevel therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (cns). the company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of cns disorders, including parkinson’s, alzheimer’s, epilepsy, ... read more
cerevel therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (cns). the company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of cns disorders, including parkinson’s, alzheimer’s, epilepsy, schizophrenia and addiction. headquartered in the greater boston area, cerevel was formed in 2018 through a partnership between bain capital and pfizer. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Anthony Coles Jr.
Full Time Employees
275
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Anthony Coles Jr.
Full Time Employees
275
URL
Address
222 Jacobs Street, Suite 200, MA, Cambridge, 02141.
PRICE CHART FOR CEREVEL THERAPEUTICS HOLDINGS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$42.10
Previous Close
$42.14
Days Range
$41.70 - $42.21
52 week range
$19.59 - $43.59
Volume
556,851
Avg. Volume (30 days)
1,153,830
Market Cap
$7.65B
Dividend Yield
-
P/E
-
Shares Outstanding
181,576,482
Open
$42.10
Previous Close
$42.14
Days Range
$41.70 - $42.21
52 week range
$19.59 - $43.59
Volume
556,851
Avg. Volume (30 days)
1,153,830
Market Cap
$7.65B
Dividend Yield
-
P/E
-
Shares Outstanding
181,576,482
FINANCIAL STATEMENTS FOR CEREVEL THERAPEUTICS HOLDINGS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CEREVEL THERAPEUTICS HOLDINGS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| COLES N ANTHONY | Director | Apr 01, 2024 | Option Exercise | $3.50 | 50,000 | 175,000 | 65,638 | Apr 03, 2024, 04:15 PM |
| COLES N ANTHONY | Director | Apr 01, 2024 | Sale | $42.33 | 50,000 | 2,116,640 | 15,638 | Apr 03, 2024, 04:15 PM |
| COLES N ANTHONY | Director | Mar 04, 2024 | Option Exercise | $3.50 | 50,000 | 175,000 | 65,638 | Mar 06, 2024, 04:15 PM |
| COLES N ANTHONY | Director | Mar 04, 2024 | Sale | $41.01 | 50,000 | 2,050,550 | 15,638 | Mar 06, 2024, 04:15 PM |
| COLES N ANTHONY | Director | Feb 29, 2024 | Option Exercise | $3.50 | 50,000 | 175,000 | 65,638 | Mar 04, 2024, 05:49 PM |
| COLES N ANTHONY | Director | Feb 29, 2024 | Sale | $41.16 | 50,000 | 2,057,890 | 15,638 | Mar 04, 2024, 05:49 PM |
| Renger John | Chief Scientific Officer | Feb 07, 2024 | Sale | $41.54 | 2,161 | 89,777 | 6,370 | Feb 08, 2024, 07:19 PM |
| COLES N ANTHONY | Director | Feb 07, 2024 | Sale | $41.54 | 2,506 | 104,110 | 15,638 | Feb 08, 2024, 07:14 PM |
| Tregoning Kathleen | See Remarks | Dec 26, 2023 | Option Exercise | $10.05 | 3,150 | 31,658 | 10,666 | Dec 28, 2023, 04:15 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 26, 2023 | Option Exercise | $3.50 | 10,000 | 35,000 | 24,673 | Dec 28, 2023, 04:15 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 26, 2023 | Sale | $42.47 | 10,000 | 424,700 | 14,673 | Dec 28, 2023, 04:15 PM |
| DiPietro Kenneth | Chief Human Resources Officer | Dec 22, 2023 | Option Exercise | $3.50 | 8,000 | 28,000 | 32,663 | Dec 27, 2023, 04:15 PM |
| DiPietro Kenneth | Chief Human Resources Officer | Dec 22, 2023 | Sale | $41.45 | 8,000 | 331,608 | 24,663 | Dec 27, 2023, 04:15 PM |
| Bodenrader Mark | See Remarks | Dec 20, 2023 | Sale | $41.42 | 7,889 | 326,788 | 17,724 | Dec 21, 2023, 08:27 PM |
| DiPietro Kenneth | Chief Human Resources Officer | Dec 20, 2023 | Sale | $41.42 | 6,256 | 259,144 | 24,663 | Dec 21, 2023, 08:24 PM |
| Akamine Scott | Chief Legal Officer | Dec 20, 2023 | Sale | $41.42 | 7,072 | 292,945 | 7,237 | Dec 21, 2023, 08:21 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 20, 2023 | Sale | $41.42 | 10,152 | 420,528 | 14,673 | Dec 21, 2023, 08:14 PM |
| ALTSCHULLER Susan | Chief Financial Officer | Dec 20, 2023 | Sale | $41.42 | 13,808 | 571,972 | 16,913 | Dec 21, 2023, 08:12 PM |
| Tregoning Kathleen | See Remarks | Dec 20, 2023 | Sale | $41.42 | 6,288 | 260,469 | 7,516 | Dec 21, 2023, 08:10 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 15, 2023 | Option Exercise | $9.88 | 7,500 | 74,100 | 7,500 | Dec 19, 2023, 04:15 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 15, 2023 | Sale | $41.39 | 7,500 | 310,393 | 0 | Dec 19, 2023, 04:15 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 07, 2023 | Option Exercise | $3.50 | 10,000 | 35,000 | 10,000 | Dec 11, 2023, 04:17 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 07, 2023 | Sale | $41.37 | 10,000 | 413,700 | 0 | Dec 11, 2023, 04:17 PM |
| Akamine Scott | Chief Legal Officer | Dec 07, 2023 | Option Exercise | $13.17 | 10,000 | 131,700 | 10,513 | Dec 07, 2023, 07:45 PM |
| Akamine Scott | Chief Legal Officer | Dec 05, 2023 | Option Exercise | $13.17 | 7,500 | 98,775 | 8,013 | Dec 07, 2023, 07:45 PM |
| Akamine Scott | Chief Legal Officer | Dec 07, 2023 | Sale | $41.37 | 10,000 | 413,700 | 513 | Dec 07, 2023, 07:45 PM |
| Akamine Scott | Chief Legal Officer | Dec 05, 2023 | Sale | $35.00 | 7,500 | 262,500 | 513 | Dec 07, 2023, 07:45 PM |
| COLES N ANTHONY | Director | Nov 14, 2023 | Option Exercise | $3.50 | 22,824 | 79,884 | 25,528 | Nov 16, 2023, 04:15 PM |
| COLES N ANTHONY | Director | Nov 14, 2023 | Sale | $25.13 | 22,824 | 573,455 | 2,704 | Nov 16, 2023, 04:15 PM |
| COLES N ANTHONY | Director | Nov 08, 2023 | Option Exercise | $3.50 | 100 | 350 | 2,804 | Nov 09, 2023, 05:03 PM |
| COLES N ANTHONY | Director | Nov 07, 2023 | Option Exercise | $3.50 | 27,076 | 94,766 | 29,780 | Nov 09, 2023, 05:03 PM |
| COLES N ANTHONY | Director | Nov 08, 2023 | Sale | $25.16 | 100 | 2,516 | 2,704 | Nov 09, 2023, 05:03 PM |
| COLES N ANTHONY | Director | Nov 07, 2023 | Sale | $25.02 | 27,076 | 677,555 | 2,704 | Nov 09, 2023, 05:03 PM |
| COLES N ANTHONY | Director | Nov 02, 2023 | Option Exercise | $3.50 | 38,599 | 135,097 | 41,303 | Nov 06, 2023, 05:12 PM |
| COLES N ANTHONY | Director | Nov 03, 2023 | Option Exercise | $3.50 | 61,401 | 214,904 | 64,105 | Nov 06, 2023, 05:12 PM |
| COLES N ANTHONY | Director | Nov 03, 2023 | Sale | $25.43 | 61,401 | 1,561,458 | 2,704 | Nov 06, 2023, 05:12 PM |
| COLES N ANTHONY | Director | Nov 02, 2023 | Sale | $25.19 | 38,599 | 972,239 | 2,704 | Nov 06, 2023, 05:12 PM |
| PATRICK DEVAL L | Director | Nov 01, 2023 | Option Exercise | $12.62 | 30,130 | 380,241 | 33,412 | Nov 03, 2023, 04:15 PM |
| PATRICK DEVAL L | Director | Nov 01, 2023 | Sale | $25.00 | 30,130 | 753,250 | 3,282 | Nov 03, 2023, 04:15 PM |
| Gordon Christopher R | Director | Oct 16, 2023 | Buy | $22.81 | 5,480,052 | 124,999,983 | 65,679,781 | Oct 18, 2023, 04:30 PM |
| Koppel Adam | Director | Oct 16, 2023 | Buy | $22.81 | 5,480,052 | 124,999,983 | 65,679,781 | Oct 18, 2023, 04:30 PM |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | Oct 16, 2023 | Buy | $22.81 | 5,480,052 | 124,999,983 | 65,679,781 | Oct 18, 2023, 04:30 PM |
| PERCEPTIVE ADVISORS LLC | Director | Oct 16, 2023 | Buy | $22.81 | 876,808 | 19,999,990 | 10,794,876 | Oct 17, 2023, 04:53 PM |
| COLES N ANTHONY | Director | Sep 07, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Sep 08, 2023, 04:35 PM |
| COLES N ANTHONY | Director | Sep 07, 2023 | Sale | $24.07 | 50,000 | 1,203,415 | 2,704 | Sep 08, 2023, 04:35 PM |
| Renaud Ronald C JR | President & CEO | Aug 03, 2023 | Buy | $23.96 | 83,857 | 2,008,811 | 83,857 | Aug 07, 2023, 05:13 PM |
| Burgess Paul D. | See Remarks | Aug 04, 2023 | Buy | $22.93 | 21,880 | 501,794 | 21,880 | Aug 07, 2023, 05:11 PM |
| COLES N ANTHONY | Director | Jul 11, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Jul 13, 2023, 05:41 PM |
| COLES N ANTHONY | Director | Jul 11, 2023 | Sale | $30.03 | 50,000 | 1,501,340 | 2,704 | Jul 13, 2023, 05:41 PM |
| DEKKERS MARIJN E | Director | Jun 15, 2023 | Sale | $34.43 | 200,000 | 6,886,000 | 402,326 | Jun 20, 2023, 04:56 PM |
| COLES N ANTHONY | CEO and Chairperson | Jun 01, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Jun 05, 2023, 08:12 PM |
| COLES N ANTHONY | CEO and Chairperson | Jun 01, 2023 | Sale | $32.60 | 50,000 | 1,630,070 | 2,704 | Jun 05, 2023, 08:12 PM |
| Bodenrader Mark | See Remarks | Jun 02, 2023 | Sale | $32.95 | 1,895 | 62,440 | 5,522 | Jun 05, 2023, 08:07 PM |
| COLES N ANTHONY | CEO and Chairperson | May 04, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | May 08, 2023, 04:24 PM |
| COLES N ANTHONY | CEO and Chairperson | May 04, 2023 | Sale | $31.47 | 50,000 | 1,573,434 | 15,136 | May 08, 2023, 04:24 PM |
| COLES N ANTHONY | CEO and Chairperson | Apr 11, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Apr 13, 2023, 04:48 PM |
| COLES N ANTHONY | CEO and Chairperson | Apr 11, 2023 | Sale | $25.06 | 50,000 | 1,253,130 | 2,704 | Apr 13, 2023, 04:48 PM |
| COLES N ANTHONY | CEO and Chairperson | Mar 03, 2023 | Option Exercise | $3.50 | 3,000 | 10,500 | 5,704 | Mar 06, 2023, 04:15 PM |
| COLES N ANTHONY | CEO and Chairperson | Mar 02, 2023 | Option Exercise | $3.50 | 47,000 | 164,500 | 49,704 | Mar 06, 2023, 04:15 PM |
| COLES N ANTHONY | CEO and Chairperson | Mar 03, 2023 | Sale | $27.19 | 3,000 | 81,570 | 2,704 | Mar 06, 2023, 04:15 PM |
| COLES N ANTHONY | CEO and Chairperson | Mar 02, 2023 | Sale | $27.11 | 47,000 | 1,274,377 | 2,704 | Mar 06, 2023, 04:15 PM |
| COLES N ANTHONY | CEO and Chairperson | Feb 07, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Feb 08, 2023, 08:27 PM |
| COLES N ANTHONY | CEO and Chairperson | Feb 07, 2023 | Sale | $33.13 | 50,000 | 1,656,401 | 10,646 | Feb 08, 2023, 08:27 PM |
| COLES N ANTHONY | CEO and Chairperson | Jan 05, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Jan 06, 2023, 05:04 PM |
| COLES N ANTHONY | CEO and Chairperson | Jan 05, 2023 | Sale | $29.94 | 50,000 | 1,496,871 | 3,204 | Jan 06, 2023, 05:04 PM |
| COLES N ANTHONY | CEO and Chairperson | Dec 09, 2022 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Dec 13, 2022, 04:44 PM |
| COLES N ANTHONY | CEO and Chairperson | Dec 09, 2022 | Sale | $26.67 | 50,000 | 1,333,300 | 7,849 | Dec 13, 2022, 04:44 PM |
| Renger John | Chief Scientific Officer | Nov 01, 2022 | Option Exercise | $7.56 | 25,000 | 189,078 | 27,704 | Nov 03, 2022, 04:28 PM |
| Renger John | Chief Scientific Officer | Nov 01, 2022 | Sale | $30.00 | 25,000 | 750,005 | 2,704 | Nov 03, 2022, 04:28 PM |
| Renger John | Chief Scientific Officer | Oct 04, 2022 | Option Exercise | $7.56 | 25,000 | 189,078 | 27,704 | Oct 06, 2022, 04:59 PM |
| Renger John | Chief Scientific Officer | Oct 04, 2022 | Sale | $30.00 | 25,000 | 750,000 | 2,704 | Oct 06, 2022, 04:59 PM |
| PATRICK DEVAL L | Director | Sep 12, 2022 | Option Exercise | $12.62 | 47,705 | 602,037 | 47,705 | Sep 14, 2022, 05:10 PM |
| PATRICK DEVAL L | Director | Sep 12, 2022 | Sale | $30.78 | 47,705 | 1,468,422 | 0 | Sep 14, 2022, 05:10 PM |
| Ceesay Abraham | President | Sep 08, 2022 | Option Exercise | $13.17 | 19,210 | 252,996 | 19,210 | Sep 12, 2022, 04:24 PM |
| Ceesay Abraham | President | Sep 08, 2022 | Sale | $32.50 | 19,210 | 624,325 | 0 | Sep 12, 2022, 04:24 PM |
| Ceesay Abraham | President | Aug 22, 2022 | Option Exercise | $13.17 | 9,605 | 126,498 | 9,605 | Aug 24, 2022, 04:05 PM |
| Ceesay Abraham | President | Aug 22, 2022 | Sale | $32.50 | 9,605 | 312,163 | 0 | Aug 24, 2022, 04:05 PM |
| PERCEPTIVE ADVISORS LLC | Director | Aug 16, 2022 | Buy | $35.00 | 1,425,000 | 49,875,000 | 6,511,727 | Aug 18, 2022, 05:10 PM |
| Ceesay Abraham | President | Aug 15, 2022 | Option Exercise | $13.17 | 9,606 | 126,511 | 9,606 | Aug 17, 2022, 04:15 PM |
| Ceesay Abraham | President | Aug 15, 2022 | Sale | $34.12 | 9,606 | 327,757 | 0 | Aug 17, 2022, 04:15 PM |
| Renger John | Chief Scientific Officer | Aug 10, 2022 | Option Exercise | $6.63 | 55,000 | 364,549 | 57,704 | Aug 12, 2022, 04:15 PM |
| Renger John | Chief Scientific Officer | Aug 10, 2022 | Sale | $40.50 | 55,000 | 2,227,624 | 21,563 | Aug 12, 2022, 04:15 PM |
| Renger John | Chief Scientific Officer | Aug 08, 2022 | Option Exercise | $3.50 | 10,000 | 35,000 | 12,704 | Aug 09, 2022, 09:23 PM |
| Renger John | Chief Scientific Officer | Aug 05, 2022 | Option Exercise | $3.50 | 20,000 | 70,000 | 22,704 | Aug 09, 2022, 09:23 PM |
| Renger John | Chief Scientific Officer | Aug 08, 2022 | Sale | $37.75 | 10,000 | 377,500 | 2,704 | Aug 09, 2022, 09:23 PM |
| Renger John | Chief Scientific Officer | Aug 05, 2022 | Sale | $32.50 | 20,000 | 650,000 | 2,704 | Aug 09, 2022, 09:23 PM |
| Akamine Scott | Chief Legal Officer | Aug 08, 2022 | Option Exercise | $13.17 | 10,000 | 131,700 | 10,000 | Aug 09, 2022, 09:18 PM |
| Akamine Scott | Chief Legal Officer | Aug 08, 2022 | Sale | $40.00 | 10,000 | 400,001 | 0 | Aug 09, 2022, 09:18 PM |
| Ceesay Abraham | President | Aug 08, 2022 | Option Exercise | $13.17 | 19,211 | 253,009 | 19,211 | Aug 09, 2022, 08:59 PM |
| Ceesay Abraham | President | Aug 05, 2022 | Option Exercise | $13.17 | 38,424 | 506,044 | 38,424 | Aug 09, 2022, 08:59 PM |
| Ceesay Abraham | President | Aug 08, 2022 | Sale | $38.62 | 19,211 | 742,024 | 9,605 | Aug 09, 2022, 08:59 PM |
| Ceesay Abraham | President | Aug 05, 2022 | Sale | $32.50 | 38,424 | 1,248,780 | 0 | Aug 09, 2022, 08:59 PM |
| Renger John | Chief Scientific Officer | Jul 20, 2022 | Option Exercise | $3.50 | 25,000 | 87,500 | 27,704 | Jul 22, 2022, 04:15 PM |
| Renger John | Chief Scientific Officer | Jul 20, 2022 | Sale | $30.00 | 25,000 | 750,000 | 2,704 | Jul 22, 2022, 04:15 PM |
| Renger John | Chief Scientific Officer | Jul 06, 2022 | Option Exercise | $3.50 | 1,105 | 3,868 | 3,809 | Jul 07, 2022, 04:06 PM |
| Renger John | Chief Scientific Officer | Jul 05, 2022 | Option Exercise | $3.50 | 25,000 | 87,500 | 27,704 | Jul 07, 2022, 04:06 PM |
| Renger John | Chief Scientific Officer | Jul 06, 2022 | Sale | $32.50 | 1,105 | 35,913 | 2,704 | Jul 07, 2022, 04:06 PM |
| Renger John | Chief Scientific Officer | Jul 05, 2022 | Sale | $30.00 | 25,000 | 750,000 | 2,704 | Jul 07, 2022, 04:06 PM |
| Renger John | Chief Scientific Officer | Apr 13, 2022 | Option Exercise | $3.50 | 45,000 | 157,500 | 46,980 | Apr 15, 2022, 04:19 PM |
| Renger John | Chief Scientific Officer | Apr 13, 2022 | Sale | $34.65 | 45,000 | 1,559,092 | 1,980 | Apr 15, 2022, 04:19 PM |
| Renger John | Chief Scientific Officer | Mar 29, 2022 | Option Exercise | $3.50 | 10,000 | 35,000 | 11,980 | Mar 31, 2022, 04:05 PM |
| Renger John | Chief Scientific Officer | Mar 29, 2022 | Sale | $35.00 | 10,000 | 350,000 | 1,980 | Mar 31, 2022, 04:05 PM |
| Renger John | Chief Scientific Officer | Mar 18, 2022 | Option Exercise | $3.50 | 20,000 | 70,000 | 21,980 | Mar 18, 2022, 07:56 PM |
| Renger John | Chief Scientific Officer | Mar 16, 2022 | Option Exercise | $3.50 | 25,000 | 87,500 | 26,980 | Mar 18, 2022, 07:56 PM |
| Renger John | Chief Scientific Officer | Mar 18, 2022 | Sale | $32.50 | 20,000 | 650,004 | 1,980 | Mar 18, 2022, 07:56 PM |
| Renger John | Chief Scientific Officer | Mar 16, 2022 | Sale | $30.00 | 25,000 | 750,005 | 1,980 | Mar 18, 2022, 07:56 PM |
| Renger John | Chief Scientific Officer | Mar 09, 2022 | Option Exercise | $3.50 | 30,000 | 105,000 | 31,980 | Mar 11, 2022, 04:08 PM |
| Renger John | Chief Scientific Officer | Mar 09, 2022 | Sale | $33.33 | 30,000 | 1,000,000 | 11,980 | Mar 11, 2022, 04:08 PM |
| Renger John | Chief Scientific Officer | Mar 02, 2022 | Option Exercise | $3.50 | 25,000 | 87,500 | 26,980 | Mar 04, 2022, 04:12 PM |
| Renger John | Chief Scientific Officer | Mar 02, 2022 | Sale | $30.00 | 25,000 | 750,000 | 1,980 | Mar 04, 2022, 04:12 PM |
| Renger John | Chief Scientific Officer | Feb 09, 2022 | Option Exercise | $3.50 | 25,000 | 87,500 | 26,980 | Feb 11, 2022, 06:46 PM |
| Renger John | Chief Scientific Officer | Feb 09, 2022 | Sale | $30.00 | 25,000 | 750,000 | 1,980 | Feb 11, 2022, 06:46 PM |
| Renger John | Chief Scientific Officer | Dec 27, 2021 | Option Exercise | $3.50 | 4,127 | 14,445 | 6,107 | Dec 28, 2021, 04:31 PM |
| Renger John | Chief Scientific Officer | Dec 23, 2021 | Option Exercise | $3.50 | 5,873 | 20,556 | 7,853 | Dec 28, 2021, 04:31 PM |
| Renger John | Chief Scientific Officer | Dec 27, 2021 | Sale | $35.00 | 4,127 | 144,445 | 1,980 | Dec 28, 2021, 04:31 PM |
| Renger John | Chief Scientific Officer | Dec 23, 2021 | Sale | $35.00 | 5,873 | 205,582 | 1,980 | Dec 28, 2021, 04:31 PM |
| Renger John | Chief Scientific Officer | Dec 21, 2021 | Option Exercise | $3.50 | 7,300 | 25,550 | 9,280 | Dec 23, 2021, 05:14 PM |
| Renger John | Chief Scientific Officer | Dec 21, 2021 | Sale | $32.50 | 7,300 | 237,250 | 1,980 | Dec 23, 2021, 05:14 PM |
| Renger John | Chief Scientific Officer | Dec 17, 2021 | Option Exercise | $3.50 | 7,122 | 24,927 | 9,102 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Dec 16, 2021 | Option Exercise | $3.50 | 5,578 | 19,523 | 7,558 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Dec 15, 2021 | Option Exercise | $3.50 | 25,000 | 87,500 | 26,980 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Dec 16, 2021 | Sale | $32.50 | 5,578 | 181,285 | 1,980 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Dec 15, 2021 | Sale | $30.02 | 25,000 | 750,448 | 1,980 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Dec 17, 2021 | Sale | $32.50 | 7,122 | 231,465 | 1,980 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Nov 10, 2021 | Option Exercise | $3.50 | 55,000 | 192,500 | 55,000 | Nov 15, 2021, 04:18 PM |
| Renger John | Chief Scientific Officer | Nov 10, 2021 | Sale | $39.86 | 55,000 | 2,192,187 | 31,368 | Nov 15, 2021, 04:18 PM |
| PERCEPTIVE ADVISORS LLC | Director | Aug 26, 2021 | Buy | $30.23 | 68,047 | 2,057,061 | 5,086,727 | Aug 31, 2021, 02:15 PM |
| PERCEPTIVE ADVISORS LLC | Director | Aug 25, 2021 | Buy | $28.57 | 61,387 | 1,753,827 | 5,018,680 | Aug 25, 2021, 07:14 PM |
| PERCEPTIVE ADVISORS LLC | Director | Aug 24, 2021 | Buy | $27.73 | 69,761 | 1,934,472 | 4,957,293 | Aug 25, 2021, 07:14 PM |
| PERCEPTIVE ADVISORS LLC | Director | Aug 23, 2021 | Buy | $25.78 | 44,437 | 1,145,586 | 4,887,532 | Aug 25, 2021, 07:14 PM |
| PERCEPTIVE ADVISORS LLC | Director | Jul 07, 2021 | Buy | $25.00 | 200,000 | 5,000,000 | 4,843,095 | Jul 09, 2021, 06:39 PM |
| Sulzberger Gabrielle | Director | Jun 17, 2021 | Buy | $13.06 | 21,084 | 275,357 | 35,354 | Jun 22, 2021, 06:31 PM |
| MISHAN ORLY | Chief Business Officer | Jan 26, 2021 | Option Exercise | $3.50 | 38,450 | 134,575 | 38,450 | Jan 28, 2021, 07:35 PM |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | Nov 09, 2020 | Buy | $10.30 | 332,293 | 3,422,618 | 60,632,356 | Nov 12, 2020, 05:54 PM |
| Koppel Adam | Director | Nov 09, 2020 | Buy | $10.30 | 332,293 | 3,422,618 | 60,632,356 | Nov 12, 2020, 05:54 PM |
| Gordon Christopher R | Director | Nov 09, 2020 | Buy | $10.30 | 332,293 | 3,422,618 | 60,632,356 | Nov 12, 2020, 05:51 PM |
| PERCEPTIVE ADVISORS LLC | Director | Oct 27, 2020 | Buy | $10.00 | 3,000,000 | 30,000,000 | 3,157,295 | Oct 29, 2020, 08:00 PM |
| Koppel Adam | Director | Oct 27, 2020 | Buy | $10.00 | 10,000,000 | 100,000,000 | 60,300,063 | Oct 29, 2020, 08:00 PM |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | Oct 27, 2020 | Buy | $10.00 | 10,000,000 | 100,000,000 | 60,300,063 | Oct 29, 2020, 08:00 PM |
| Gordon Christopher R | Director | Oct 27, 2020 | Buy | $10.00 | 10,000,000 | 100,000,000 | 60,300,063 | Oct 29, 2020, 08:00 PM |
| PFIZER INC | 10% Owner | Oct 27, 2020 | Buy | $10.00 | 1,200,000 | 12,000,000 | 27,349,211 | Oct 29, 2020, 05:44 PM |
| PERCEPTIVE ADVISORS LLC | Director | Oct 21, 2020 | Buy | $10.09 | 43,195 | 435,838 | 157,295 | Oct 22, 2020, 08:34 PM |
| PERCEPTIVE ADVISORS LLC | Director | Oct 20, 2020 | Buy | $10.00 | 114,100 | 1,141,000 | 114,100 | Oct 22, 2020, 08:34 PM |
| ARYA Sciences Holdings II | 10% Owner | Jun 09, 2020 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Jun 09, 2020, 08:25 PM |
| Stone Adam Leo | Chief Executive Officer | Jun 09, 2020 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Jun 09, 2020, 08:25 PM |
| ALTMAN MICHAEL SETH | Chief Financial Officer | Jun 09, 2020 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Jun 09, 2020, 08:23 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| COLES N ANTHONY | Director | 04/01/2024 | 175,000 |
| COLES N ANTHONY | Director | 04/01/2024 | 2,116,640 |
| COLES N ANTHONY | Director | 03/04/2024 | 175,000 |
| COLES N ANTHONY | Director | 03/04/2024 | 2,050,550 |
| COLES N ANTHONY | Director | 02/29/2024 | 175,000 |
| COLES N ANTHONY | Director | 02/29/2024 | 2,057,890 |
| Renger John | Chief Scientific Officer | 02/07/2024 | 89,777 |
| COLES N ANTHONY | Director | 02/07/2024 | 104,110 |
| Tregoning Kathleen | See Remarks | 12/26/2023 | 31,658 |
| Sanchez Ramiro | Chief Medical Officer | 12/26/2023 | 35,000 |
| Sanchez Ramiro | Chief Medical Officer | 12/26/2023 | 424,700 |
| DiPietro Kenneth | Chief Human Resources Officer | 12/22/2023 | 28,000 |
| DiPietro Kenneth | Chief Human Resources Officer | 12/22/2023 | 331,608 |
| Bodenrader Mark | See Remarks | 12/20/2023 | 326,788 |
| DiPietro Kenneth | Chief Human Resources Officer | 12/20/2023 | 259,144 |
| Akamine Scott | Chief Legal Officer | 12/20/2023 | 292,945 |
| Sanchez Ramiro | Chief Medical Officer | 12/20/2023 | 420,528 |
| ALTSCHULLER Susan | Chief Financial Officer | 12/20/2023 | 571,972 |
| Tregoning Kathleen | See Remarks | 12/20/2023 | 260,469 |
| Sanchez Ramiro | Chief Medical Officer | 12/15/2023 | 74,100 |
| Sanchez Ramiro | Chief Medical Officer | 12/15/2023 | 310,393 |
| Sanchez Ramiro | Chief Medical Officer | 12/07/2023 | 35,000 |
| Sanchez Ramiro | Chief Medical Officer | 12/07/2023 | 413,700 |
| Akamine Scott | Chief Legal Officer | 12/07/2023 | 131,700 |
| Akamine Scott | Chief Legal Officer | 12/05/2023 | 98,775 |
| Akamine Scott | Chief Legal Officer | 12/07/2023 | 413,700 |
| Akamine Scott | Chief Legal Officer | 12/05/2023 | 262,500 |
| COLES N ANTHONY | Director | 11/14/2023 | 79,884 |
| COLES N ANTHONY | Director | 11/14/2023 | 573,455 |
| COLES N ANTHONY | Director | 11/08/2023 | 350 |
| COLES N ANTHONY | Director | 11/07/2023 | 94,766 |
| COLES N ANTHONY | Director | 11/08/2023 | 2,516 |
| COLES N ANTHONY | Director | 11/07/2023 | 677,555 |
| COLES N ANTHONY | Director | 11/02/2023 | 135,097 |
| COLES N ANTHONY | Director | 11/03/2023 | 214,904 |
| COLES N ANTHONY | Director | 11/03/2023 | 1,561,458 |
| COLES N ANTHONY | Director | 11/02/2023 | 972,239 |
| PATRICK DEVAL L | Director | 11/01/2023 | 380,241 |
| PATRICK DEVAL L | Director | 11/01/2023 | 753,250 |
| Gordon Christopher R | Director | 10/16/2023 | 124,999,983 |
| Koppel Adam | Director | 10/16/2023 | 124,999,983 |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | 10/16/2023 | 124,999,983 |
| PERCEPTIVE ADVISORS LLC | Director | 10/16/2023 | 19,999,990 |
| COLES N ANTHONY | Director | 09/07/2023 | 175,000 |
| COLES N ANTHONY | Director | 09/07/2023 | 1,203,415 |
| Renaud Ronald C JR | President & CEO | 08/03/2023 | 2,008,811 |
| Burgess Paul D. | See Remarks | 08/04/2023 | 501,794 |
| COLES N ANTHONY | Director | 07/11/2023 | 175,000 |
| COLES N ANTHONY | Director | 07/11/2023 | 1,501,340 |
| DEKKERS MARIJN E | Director | 06/15/2023 | 6,886,000 |
| COLES N ANTHONY | CEO and Chairperson | 06/01/2023 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 06/01/2023 | 1,630,070 |
| Bodenrader Mark | See Remarks | 06/02/2023 | 62,440 |
| COLES N ANTHONY | CEO and Chairperson | 05/04/2023 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 05/04/2023 | 1,573,434 |
| COLES N ANTHONY | CEO and Chairperson | 04/11/2023 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 04/11/2023 | 1,253,130 |
| COLES N ANTHONY | CEO and Chairperson | 03/03/2023 | 10,500 |
| COLES N ANTHONY | CEO and Chairperson | 03/02/2023 | 164,500 |
| COLES N ANTHONY | CEO and Chairperson | 03/03/2023 | 81,570 |
| COLES N ANTHONY | CEO and Chairperson | 03/02/2023 | 1,274,377 |
| COLES N ANTHONY | CEO and Chairperson | 02/07/2023 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 02/07/2023 | 1,656,401 |
| COLES N ANTHONY | CEO and Chairperson | 01/05/2023 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 01/05/2023 | 1,496,871 |
| COLES N ANTHONY | CEO and Chairperson | 12/09/2022 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 12/09/2022 | 1,333,300 |
| Renger John | Chief Scientific Officer | 11/01/2022 | 189,078 |
| Renger John | Chief Scientific Officer | 11/01/2022 | 750,005 |
| Renger John | Chief Scientific Officer | 10/04/2022 | 189,078 |
| Renger John | Chief Scientific Officer | 10/04/2022 | 750,000 |
| PATRICK DEVAL L | Director | 09/12/2022 | 602,037 |
| PATRICK DEVAL L | Director | 09/12/2022 | 1,468,422 |
| Ceesay Abraham | President | 09/08/2022 | 252,996 |
| Ceesay Abraham | President | 09/08/2022 | 624,325 |
| Ceesay Abraham | President | 08/22/2022 | 126,498 |
| Ceesay Abraham | President | 08/22/2022 | 312,163 |
| PERCEPTIVE ADVISORS LLC | Director | 08/16/2022 | 49,875,000 |
| Ceesay Abraham | President | 08/15/2022 | 126,511 |
| Ceesay Abraham | President | 08/15/2022 | 327,757 |
| Renger John | Chief Scientific Officer | 08/10/2022 | 364,549 |
| Renger John | Chief Scientific Officer | 08/10/2022 | 2,227,624 |
| Renger John | Chief Scientific Officer | 08/08/2022 | 35,000 |
| Renger John | Chief Scientific Officer | 08/05/2022 | 70,000 |
| Renger John | Chief Scientific Officer | 08/08/2022 | 377,500 |
| Renger John | Chief Scientific Officer | 08/05/2022 | 650,000 |
| Akamine Scott | Chief Legal Officer | 08/08/2022 | 131,700 |
| Akamine Scott | Chief Legal Officer | 08/08/2022 | 400,001 |
| Ceesay Abraham | President | 08/08/2022 | 253,009 |
| Ceesay Abraham | President | 08/05/2022 | 506,044 |
| Ceesay Abraham | President | 08/08/2022 | 742,024 |
| Ceesay Abraham | President | 08/05/2022 | 1,248,780 |
| Renger John | Chief Scientific Officer | 07/20/2022 | 87,500 |
| Renger John | Chief Scientific Officer | 07/20/2022 | 750,000 |
| Renger John | Chief Scientific Officer | 07/06/2022 | 3,868 |
| Renger John | Chief Scientific Officer | 07/05/2022 | 87,500 |
| Renger John | Chief Scientific Officer | 07/06/2022 | 35,913 |
| Renger John | Chief Scientific Officer | 07/05/2022 | 750,000 |
| Renger John | Chief Scientific Officer | 04/13/2022 | 157,500 |
| Renger John | Chief Scientific Officer | 04/13/2022 | 1,559,092 |
| Renger John | Chief Scientific Officer | 03/29/2022 | 35,000 |
| Renger John | Chief Scientific Officer | 03/29/2022 | 350,000 |
| Renger John | Chief Scientific Officer | 03/18/2022 | 70,000 |
| Renger John | Chief Scientific Officer | 03/16/2022 | 87,500 |
| Renger John | Chief Scientific Officer | 03/18/2022 | 650,004 |
| Renger John | Chief Scientific Officer | 03/16/2022 | 750,005 |
| Renger John | Chief Scientific Officer | 03/09/2022 | 105,000 |
| Renger John | Chief Scientific Officer | 03/09/2022 | 1,000,000 |
| Renger John | Chief Scientific Officer | 03/02/2022 | 87,500 |
| Renger John | Chief Scientific Officer | 03/02/2022 | 750,000 |
| Renger John | Chief Scientific Officer | 02/09/2022 | 87,500 |
| Renger John | Chief Scientific Officer | 02/09/2022 | 750,000 |
| Renger John | Chief Scientific Officer | 12/27/2021 | 14,445 |
| Renger John | Chief Scientific Officer | 12/23/2021 | 20,556 |
| Renger John | Chief Scientific Officer | 12/27/2021 | 144,445 |
| Renger John | Chief Scientific Officer | 12/23/2021 | 205,582 |
| Renger John | Chief Scientific Officer | 12/21/2021 | 25,550 |
| Renger John | Chief Scientific Officer | 12/21/2021 | 237,250 |
| Renger John | Chief Scientific Officer | 12/17/2021 | 24,927 |
| Renger John | Chief Scientific Officer | 12/16/2021 | 19,523 |
| Renger John | Chief Scientific Officer | 12/15/2021 | 87,500 |
| Renger John | Chief Scientific Officer | 12/16/2021 | 181,285 |
| Renger John | Chief Scientific Officer | 12/15/2021 | 750,448 |
| Renger John | Chief Scientific Officer | 12/17/2021 | 231,465 |
| Renger John | Chief Scientific Officer | 11/10/2021 | 192,500 |
| Renger John | Chief Scientific Officer | 11/10/2021 | 2,192,187 |
| PERCEPTIVE ADVISORS LLC | Director | 08/26/2021 | 2,057,061 |
| PERCEPTIVE ADVISORS LLC | Director | 08/25/2021 | 1,753,827 |
| PERCEPTIVE ADVISORS LLC | Director | 08/24/2021 | 1,934,472 |
| PERCEPTIVE ADVISORS LLC | Director | 08/23/2021 | 1,145,586 |
| PERCEPTIVE ADVISORS LLC | Director | 07/07/2021 | 5,000,000 |
| Sulzberger Gabrielle | Director | 06/17/2021 | 275,357 |
| MISHAN ORLY | Chief Business Officer | 01/26/2021 | 134,575 |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | 11/09/2020 | 3,422,618 |
| Koppel Adam | Director | 11/09/2020 | 3,422,618 |
| Gordon Christopher R | Director | 11/09/2020 | 3,422,618 |
| PERCEPTIVE ADVISORS LLC | Director | 10/27/2020 | 30,000,000 |
| Koppel Adam | Director | 10/27/2020 | 100,000,000 |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | 10/27/2020 | 100,000,000 |
| Gordon Christopher R | Director | 10/27/2020 | 100,000,000 |
| PFIZER INC | 10% Owner | 10/27/2020 | 12,000,000 |
| PERCEPTIVE ADVISORS LLC | Director | 10/21/2020 | 435,838 |
| PERCEPTIVE ADVISORS LLC | Director | 10/20/2020 | 1,141,000 |
| ARYA Sciences Holdings II | 10% Owner | 06/09/2020 | 4,990,000 |
| Stone Adam Leo | Chief Executive Officer | 06/09/2020 | 4,990,000 |
| ALTMAN MICHAEL SETH | Chief Financial Officer | 06/09/2020 | 4,990,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CEREVEL THERAPEUTICS HOLDINGS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 6,027,525 | 0.00652% | 20.77% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 1,941,215 | 0.15% | 6415.02% | Event Driven |
| GEODE CAPITAL MANAGEMENT, LLC | 1,789,302 | 0.00794% | 24.32% | Other |
| BAKER BROS. ADVISORS LP | 1,600,000 | 0.77% | New | Other |
| PENTWATER CAPITAL MANAGEMENT LP | 1,100,000 | 0.52% | New | Event Driven |
| MAGNETAR FINANCIAL LLC | 1,018,428 | 1.1% | New | Event Driven, Other |
| AQR ARBITRAGE LLC | 933,764 | 1.6% | New | Event Driven |
| WESTCHESTER CAPITAL MANAGEMENT, LLC | 729,310 | 1.08% | New | Event Driven |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 619,206 | 0.05% | -58.88% | Other |
| WATER ISLAND CAPITAL LLC | 588,100 | 2.55% | New | Event Driven |
| FARALLON CAPITAL MANAGEMENT LLC | 567,321 | 0.12% | New | Event Driven, Value |
| GABELLI FUNDS LLC | 465,621 | 0.15% | New | Event Driven, Growth, Activists |
| MELQART ASSET MANAGEMENT (UK) LTD | 286,393 | 0.89% | New | Event Driven |
| RENAISSANCE TECHNOLOGIES LLC | 239,500 | 0.02% | New | Other |
| TWIN SECURITIES, INC. | 232,705 | 10.41% | New | Event Driven |
| BALYASNY ASSET MANAGEMENT L.P. | 225,000 (Call) | 0.02% | New | Event Driven |
| WESTCHESTER CAPITAL MANAGEMENT, LLC | 200,000 (Put) | 0.3% | New | Event Driven |
| CANDRIAM S.C.A. | 167,221 | 0.05% | -48.9% | Other |
| ALPS ADVISORS INC | 97,689 | 0.03% | -15.98% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 62,100 (Put) | 0.00494% | New | Event Driven |
| KELLNER CAPITAL, LLC | 20,300 | 1.55% | New | Event Driven |
| AQR CAPITAL MANAGEMENT LLC | 19,578 | 0.00156% | New | Other |
| BLACKSTONE INC. | 14,545 | 0.00277% | New | Other |
| GOTHAM ASSET MANAGEMENT, LLC | 9,394 | 0.00739% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR CEREVEL THERAPEUTICS HOLDINGS INC
STOCK BUYBACKS FOR CEREVEL THERAPEUTICS HOLDINGS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
12.39%
1Q
06/30/2023
12.71%
2Q
03/31/2023
13.00%
3Q
12/31/2022
13.16%
4Q
09/30/2022
16.23%
5Q
06/30/2022
19.37%
6Q
03/31/2022
19.62%
7Q
12/31/2021
20.10%
8Q
09/30/2021
22.91%
9Q
06/30/2021
38.86%
10Q
03/31/2021
39.14%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CEREVEL THERAPEUTICS HOLDINGS INC
LOADING...